Today is monthly options expiry day — June 29 — and the market is sending mixed signals heading into the half-year close.
SPY and NVDA both carry same-day expiries, making this a high-gamma session. Dealers must hedge aggressively as contracts roll off. That creates sharp intraday price swings, particularly in tech.
NVDA has the most active expiry calendar on the board. Options chains run daily through early July. Its ORTEX momentum score slipped from 62.8 to 53.0 since mid-June. That 10-point drop is notable. Traders appear to be rotating hedges rather than adding fresh calls.
AMD shows a thinner expiry strip, with the nearest dated contract sitting at July 2. That gap suggests traders are looking past this week. The September 18 and 22 expiries have attracted attention, pointing to bets tied to Q2 earnings season.
HCA Healthcare drew fresh attention today after gene-editing research was published in the NEJM. Options expiries out to September 18 are active. Short interest sits at just 3.7% of free float. That makes a squeeze less likely, but call buyers may be positioning ahead of any biotech catalyst.
Playboy joined the Russell 2000 and Russell 3000 today. Index inclusion forces passive funds to buy. Its options market is thin — just July 17 and August 21 expiries — but a rebalancing event of this kind often triggers short-term call activity as traders front-run passive flows.
The broader picture: AI-linked stocks face a BIS warning on "exuberance," which may weigh on call sentiment in semiconductors. Watch the SPY put/call flow into the close.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
